Bristol Myers Squibb, after passing on Acceleron, now eyes Aurinia takeout: Bloomberg

Bristol Myers Squibb, after passing on Acceleron, now eyes Aurinia takeout: Bloomberg
esagonowsky
Fri, 10/22/2021 – 16:15